Literature DB >> 5411870

Lack of platelet response to stimulation in the Wiskott-Aldrich syndrome.

A Kuramoto, M Steiner, M G Baldini.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1970        PMID: 5411870     DOI: 10.1056/NEJM197002262820904

Source DB:  PubMed          Journal:  N Engl J Med        ISSN: 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  8 in total

Review 1.  The Wiskott-Aldrich syndrome.

Authors:  H D Ochs
Journal:  Clin Rev Allergy Immunol       Date:  2001-02       Impact factor: 8.667

Review 2.  The Wiskott-Aldrich syndrome.

Authors:  A J Thrasher; C Kinnon
Journal:  Clin Exp Immunol       Date:  2000-04       Impact factor: 4.330

Review 3.  The Wiskott-Aldrich syndrome.

Authors:  H D Ochs
Journal:  Springer Semin Immunopathol       Date:  1998

Review 4.  Platelet disorders: a review of disturbances in adhesion, aggregation, and release reaction.

Authors:  M A Sahud
Journal:  Calif Med       Date:  1972-01

Review 5.  Wiskott-Aldrich syndrome.

Authors:  S Nonoyama; H D Ochs
Journal:  Curr Allergy Asthma Rep       Date:  2001-09       Impact factor: 4.806

6.  Intravenous immunoglobulin, splenectomy, and antibiotic prophylaxis in Wiskott-Aldrich syndrome.

Authors:  J Litzman; A Jones; I Hann; H Chapel; S Strobel; G Morgan
Journal:  Arch Dis Child       Date:  1996-11       Impact factor: 3.791

7.  Effects of eltrombopag on platelet count and platelet activation in Wiskott-Aldrich syndrome/X-linked thrombocytopenia.

Authors:  Anja J Gerrits; Emily A Leven; Andrew L Frelinger; Sophie L Brigstocke; Michelle A Berny-Lang; W Beau Mitchell; Shoshana Revel-Vilk; Hannah Tamary; Sabrina L Carmichael; Marc R Barnard; Alan D Michelson; James B Bussel
Journal:  Blood       Date:  2015-07-29       Impact factor: 22.113

8.  The Wiskott-Aldrich syndrome. Results of transfer factor therapy.

Authors:  L E Spitler; A S Levin; D P Stites; H H Fudenberg; B Pirofsky; C S August; E R Stiehm; W H Hitzig; R A Gatti
Journal:  J Clin Invest       Date:  1972-12       Impact factor: 14.808

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.